Timing and impact of decisions to adjust disease ‐modifying antirheumatic drug therapy for rheumatoid arthritis patients with active disease

ConclusionAdjusting DMARDs within 90 days was associated with shorter times to LDAS, but many patients with persistent MHDAS waited more than 90 days to adjust DMARDs. Interventions are needed to address the timeliness of DMARD adjustments for RA patients with MHDAS.This article is protected by copyright. All rights reserved.
Source: Arthritis Care and Research - Category: Rheumatology Authors: Tags: Original Article Source Type: research